RACHEL MENDENHALL: Open Payments
NPI 1760760185 · ASHLAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 13 payments from 8 companies in 2025. Trend: 2023 $490 · 2024 $249 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Amneal Pharmaceuticals LLC | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: INGREZZA, CREXONT, BREZTRI, VYALEV, QULIPTA, ZENPEP, EVENITY, Kerendia.
Industry payments across OH — which companies pay providers there.
